Inactief instrument

Koers 20/20 GeneSystems Inc.

Aandelen

Duur

Periode

Stijl

20/20 GeneSystems Inc. announced that it expects to receive $4.999995 million in funding	15-08-22
20/20 GeneSystems, Inc. Launches First Accelerator Facility for Innovative Clinical Lab Tests	28-09-21
20/20 GeneSystems, Inc. announced that it has received $2 million in funding	04-02-16
20/20 GeneSystems, Inc. announced that it expects to receive $3 million in funding.	28-01-16
20/20 GeneSystems, Inc. announced that it has received $4.5 million in funding from Ping An Ventures and other investors.	14-01-16

Managers	Titel	Leeftijd	Van
Jonathan Cohen CEO	Chief Executive Officer	-	01-01-08
Nora Li PRN	Corporate Officer/Principal	-	-

Besturend	Titel	Leeftijd	Van
Richard Cohen BRD	Director/Board Member	73	01-01-16
Jonathan Cohen CEO	Chief Executive Officer	-	01-01-08
John Compton BRD	Director/Board Member	-	-

Sector